IMPAVIDO
NDC 69051-300, miltefosine, capsule, from Profounda, Inc..
- Product NDC
- 69051-300
- Status
- Listed
- Labeler
- Profounda, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204684
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69051-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MILTEFOSINE50 mg/1
Pharmacologic classes
Antileishmanial [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69051-300-01 | 69051030001 | 2 BLISTER PACK in 1 CARTON (69051-300-01) / 14 CAPSULE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bcb387ac-2e90-4f5e-94b2-d3635190678e
Use it
Look up 69051-300 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69051-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69051-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.